{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:31:45Z","timestamp":1792690305633,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Natural killer (NK) cells are increasingly recognized as central effectors in kidney allograft injury, extending beyond their traditional role in innate immunity. This narrative review summarizes current evidence linking NK cells to microvascular inflammation, with a focus on both antibody-dependent and antibody-independent rejection. In antibody-mediated rejection, NK cells may be activated through Fc gamma receptor IIIa (CD16a) engagement with endothelium-bound donor-specific antibodies, leading to antibody-dependent cellular cytotoxicity and proinflammatory cytokine release. In parallel, emerging data highlight donor-specific antibody-independent pathways of NK cell activation, most prominently \u201cmissing-self\u201d recognition, driven by donor-recipient killer immunoglobulin-like receptor\u2013HLA incompatibility. Direct proof of concept for an effector role of NK cells in rejection comes from a series of experimental models. High-dimensional transcriptomic and spatial profiling of clinical transplant biopsies consistently demonstrate NK cell enrichment in antibody-mediated rejection and microvascular inflammation, with expression signatures correlating with graft injury severity and outcomes. Moreover, functional genetic polymorphisms in NK cell receptors, including Fc gamma receptor IIIa and the activating receptor NK group 2 member C, might modulate NK cell responsiveness and as a consequence susceptibility to microvascular injury. Therapeutically, emerging strategies such as CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      targeting monoclonal antibodies, mammalian target of rapamycin inhibition, and, still in experimental phase, interleukin-15 blockade suggest potential to modulate NK cell activity and counteract rejection. Collectively, these findings position NK cells as central effector cells integrating innate and adaptive alloimmune responses and highlight them as promising therapeutic targets in kidney transplantation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005837","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:00:20Z","timestamp":1783526420000},"page":"e1779-e1788","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Natural Killer Cells in Kidney Transplantation"],"prefix":"10.1097","volume":"110","author":[{"given":"Matthias","family":"Diebold","sequence":"first","affiliation":[{"name":"Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, University of Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela M.","family":"Allmer","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Vietzen","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection.","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","article-title":"Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.","volume":"95","author":"Yazdani","year":"2019","journal-title":"Kidney Int"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes.","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.it.2026.01.009","article-title":"Molecular determinants of NK cell memory.","volume":"47","author":"Owyong","year":"2026","journal-title":"Trends Immunol"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2022.10.014","article-title":"The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients.","volume":"42","author":"Vietzen","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am J Transplant"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing self-induced microvascular rejection of kidney allografts: a population-based study.","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection.","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"e2516594123","DOI":"10.1073\/pnas.2516594123","article-title":"Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection.","volume":"123","author":"Hamada","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"e20231222","DOI":"10.1084\/jem.20231222","article-title":"Five decades of natural killer cell discovery.","volume":"221","author":"Lanier","year":"2024","journal-title":"J Exp Med"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity.","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity.","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat Immunol"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.2006.00457.x","article-title":"Activation, coactivation, and costimulation of resting human natural killer cells.","volume":"214","author":"Bryceson","year":"2006","journal-title":"Immunol Rev"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/2326-6066.CIR-17-0550","article-title":"CD16A activation of NK cells promotes NK cell proliferation and memory-like cytotoxicity against cancer cells.","volume":"6","author":"Pahl","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4614-0106-3_8","article-title":"Granzyme B: a new crossroad of complement and apoptosis.","volume":"946","author":"Perl","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-025-08713-9","article-title":"Granzyme K activates the entire complement cascade.","volume":"641","author":"Donado","year":"2025","journal-title":"Nature"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"108374","DOI":"10.1016\/j.intimp.2021.108374","article-title":"Crosstalk between macrophages and natural killer cells in the tumor microenvironment.","volume":"101","author":"Zhou","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.kint.2023.04.024","article-title":"Interleukin-21 promotes type-1 activation and cytotoxicity of CD56(dim)CD16(bright) natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.","volume":"104","author":"Bailly","year":"2023","journal-title":"Kidney Int"},{"key":"R22-20260824","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.kint.2016.02.030","article-title":"Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.","volume":"89","author":"Kohei","year":"2016","journal-title":"Kidney Int"},{"key":"R23-20260824","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/ajt.13865","article-title":"Interferon gamma and contact-dependent cytotoxicity are each rate limiting for natural killer cell-mediated antibody-dependent chronic rejection.","volume":"16","author":"Lin","year":"2016","journal-title":"Am J Transplant"},{"key":"R24-20260824","doi-asserted-by":"crossref","first-page":"e20220022","DOI":"10.1084\/jem.20220022","article-title":"The CD3zeta adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling.","volume":"219","author":"Aguilar","year":"2022","journal-title":"J Exp Med"},{"key":"R25-20260824","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fimmu.2014.00145","article-title":"Ly49 receptors: innate and adaptive immune paradigms.","volume":"5","author":"Rahim","year":"2014","journal-title":"Front Immunol"},{"key":"R26-20260824","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/TP.0000000000005228","article-title":"Functional natural killer-cell genetics and microvascular inflammation after kidney transplantation: an observational cohort study.","volume":"109","author":"Diebold","year":"2025","journal-title":"Transplantation"},{"key":"R27-20260824","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.ajt.2025.04.024","article-title":"Alloreactive adaptive natural killer cells in renal transplantation: potential contribution to allograft microvascular inflammation.","volume":"25","author":"Alari-Pahissa","year":"2025","journal-title":"Am J Transplant"},{"key":"R28-20260824","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.1074\/jbc.M112.409672","article-title":"Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.","volume":"288","author":"Heatley","year":"2013","journal-title":"J Biol Chem"},{"key":"R29-20260824","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-6143.2008.02526.x","article-title":"Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention.","volume":"9","author":"Suarez-Alvarez","year":"2009","journal-title":"Am J Transplant"},{"key":"R30-20260824","doi-asserted-by":"crossref","first-page":"e15719","DOI":"10.1111\/tan.15719","article-title":"Peptide sharing between CMV and mismatched HLA class I peptides promotes early T-cell-mediated rejection after kidney transplantation.","volume":"104","author":"Peereboom","year":"2024","journal-title":"HLA"},{"key":"R31-20260824","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/ajt.13115","article-title":"The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors.","volume":"15","author":"Venner","year":"2015","journal-title":"Am J Transplant"},{"key":"R32-20260824","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.3389\/ti.2024.13209","article-title":"Natural killer cell presence in antibody-mediated rejection.","volume":"37","author":"Diebold","year":"2024","journal-title":"Transpl Int"},{"key":"R33-20260824","doi-asserted-by":"crossref","first-page":"e185687","DOI":"10.1172\/jci.insight.185687","article-title":"High-dimensional analysis of NK cells in kidney transplantation uncovers subsets associated with antibody-independent graft dysfunction.","volume":"9","author":"Ruan","year":"2024","journal-title":"JCI Insight"},{"key":"R34-20260824","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","article-title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.","volume":"189","author":"Foley","year":"2012","journal-title":"J Immunol"},{"key":"R35-20260824","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3389\/fimmu.2019.03106","article-title":"Immune cell infiltrate in chronic-active antibody-mediated rejection.","volume":"10","author":"Sablik","year":"2019","journal-title":"Front Immunol"},{"key":"R36-20260824","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ajt.14410","article-title":"Mechanistic sharing between NK cells in ABMR and effector T cells in TCMR.","volume":"18","author":"Parkes","year":"2018","journal-title":"Am J Transplant"},{"key":"R37-20260824","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","article-title":"Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.","volume":"24","author":"Diebold","year":"2024","journal-title":"Am J Transplant"},{"key":"R38-20260824","doi-asserted-by":"crossref","first-page":"829228","DOI":"10.3389\/fimmu.2022.829228","article-title":"Deletion of the natural killer cell receptor NKG2C encoding KLR2C gene and kidney transplant outcome.","volume":"13","author":"Vietzen","year":"2022","journal-title":"Front Immunol"},{"key":"R39-20260824","doi-asserted-by":"crossref","first-page":"724331","DOI":"10.3389\/fimmu.2021.724331","article-title":"Functional Fc gamma receptor gene polymorphisms and long-term kidney allograft survival.","volume":"12","author":"Wahrmann","year":"2021","journal-title":"Front Immunol"},{"key":"R40-20260824","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1038\/s41598-021-86943-3","article-title":"The FCGR3A 158 V\/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection.","volume":"11","author":"Litjens","year":"2021","journal-title":"Sci Rep"},{"key":"R41-20260824","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/ajt.14710","article-title":"Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.","volume":"18","author":"Arnold","year":"2018","journal-title":"Am J Transplant"},{"key":"R42-20260824","doi-asserted-by":"crossref","first-page":"1440887","DOI":"10.3389\/fimmu.2024.1440887","article-title":"MICA and NKG2D gene polymorphisms influence graft survival, and response to therapy in kidney transplantation.","volume":"15","author":"Littera","year":"2024","journal-title":"Front Immunol"},{"key":"R43-20260824","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3389\/fimmu.2019.02279","article-title":"Natural killer cells promote kidney graft rejection independently of cyclosporine A therapy.","volume":"10","author":"Ashraf","year":"2019","journal-title":"Front Immunol"},{"key":"R44-20260824","doi-asserted-by":"crossref","first-page":"14343","DOI":"10.3389\/ti.2025.14343","article-title":"Targeting CD38 in antibody-mediated rejection.","volume":"38","author":"Mayer","year":"2025","journal-title":"Transpl Int"},{"key":"R45-20260824","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/TP.0000000000003247","article-title":"CD38 antibody daratumumab for the treatment of chronic active antibody-mediated kidney allograft rejection.","volume":"105","author":"Doberer","year":"2021","journal-title":"Transplantation"},{"key":"R46-20260824","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"R47-20260824","doi-asserted-by":"crossref","first-page":"e70560","DOI":"10.1111\/tan.70560","article-title":"Acute rejection with DSA-negative severe microvascular inflammation in a kidney transplant recipient with an isolated DPB1*04-mismatch successfully stabilised with daratumumab.","volume":"107","author":"Kn\u00f6dl","year":"2026","journal-title":"HLA"},{"key":"R48-20260824","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1097\/TP.0000000000005608","article-title":"Adjuvant IL-15 blockade significantly improves survival in a CD28-based immunosuppression protocol of pig-to-nonhuman primate renal xenotransplantation.","volume":"110","author":"Keiler","year":"2026","journal-title":"Transplantation"},{"key":"R49-20260824","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.trim.2011.07.002","article-title":"Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation.","volume":"25","author":"Sageshima","year":"2011","journal-title":"Transpl Immunol"},{"key":"R50-20260824","doi-asserted-by":"crossref","first-page":"599526","DOI":"10.3389\/fimmu.2021.599526","article-title":"Siplizumab induces NK cell fratricide through antibody-dependent cell-mediated cytotoxicity.","volume":"12","author":"Binder","year":"2021","journal-title":"Front Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:10:17Z","timestamp":1787577017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005837","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}